FOLD Key Stats
|Revenue (Quarterly YoY Growth)||-100.0%|
|EPS Diluted (TTM)||-1.152|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-57.41M|
|Gross Profit Margin (Quarterly)|
|Profit Margin (Quarterly)||-37408%|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM) Pro||Go Pro|
- Short Interest In Amicus Therapeutics Drops 10.6% The Street Dec 11
- Amicus Therapeutics (FOLD) Files 19.3M Common Shelf for Shareholders Street Insider Dec 10
- AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib Dec 5
- Amicus Takes A Certain Step Back For An Uncertain Step Forward Dec 3
- In Insider Trading, Purchases by GlaxoSmithKline and Noted Biotech Investor Randal Kirk Nov 25
- Top Insider Trades: OGEN, FOLD, ACHN, ZINC Nov 25
- Update on Glaxo-Amicus Deal - Analyst Blog Zacks Nov 22
- Amicus Therapeutics' CEO Hosts Strategic Update Conference (Transcript) Seeking Alpha Nov 21
- Notable 52-Week Highs and Lows of the Day 11/21: (ENT) (JCI) (NUS) High; (LQDT) (JOE) (FOLD) Low Street Insider Nov 21
- Notable Mergers and Acquisitions of the Day 11/21: (FOLD) (ALEX) (CKEC) Street Insider Nov 21
FOLD Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Amicus Therapeutics is down 62.20% over the last year vs S&P 500 Total Return up 28.99%, Theravance up 55.68%, and GlaxoSmithKline up 21.67%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for FOLD
Pro Strategies Featuring FOLD
Did Amicus Therapeutics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Amicus Therapeutics, Inc. is a biopharmaceutical company in the development stage. Its activities include raising capital, establishing facilities, and performing research and development.